1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6E6AFA3D536AB7FF7002588A000505A5D
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-medical-affairs-patient-engagement-internal-external-collaboration?opendocument
18
19opendocument
2034.239.154.240
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Patient Advocacy

Medical Affairs and Patient Engagement: Internal and External Collaboration

ID: 5732


Features:

11 Info Graphics

15 Data Graphics

340+ Metrics

4 Narratives


Pages/Slides: 33


Published: 2022


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Medical Affairs and Patient Engagement: Internal and External Collaboration”

STUDY OVERVIEW

As a key conduit between pharma and patients, Medical Affairs groups have been charged with representing the patient voice at the biopharma company. While this effort broadens medical’s role beyond its traditional focus on HCPs, Medical Affairs needs to collaborate with several internal and external groups to effectively capture patient voice to help develop products that will address patients’ needs.

Best Practices, LLC conducted this benchmarking research to understand Medical Affairs’ role in patient engagement. The study specifically looks at Medical Affairs’ collaboration with internal and external groups for effective patient engagement. It also examines the critical lessons learned and pitfalls encountered in representing the patient voice through Medical Affairs.

Data in this study are segmented by respondents’ description of their medical team’s effectiveness with patient engagement – highly effective vs. less effective.

KEY TOPICS

  • Patient Engagement Overview
  • Collaboration with Internal Groups
  • Collaboration with External Groups
  • Lessons Learned in Representing the Patient Voice through Medical Affairs
  • Pitfalls or Stumbling Blocks Encountered in Representing the Patient Voice

KEY METRICS

  • How effective is the collaboration between Medical Affairs and internal groups on different patient engagement tasks?
  • How effective is the collaboration between Medical Affairs and external partners on different patient engagement activities?
  • How involved is each specific part of the Medical Affairs organization in patient engagement activities?
  • How often does Medical Affairs collaborate with different internal groups on patient engagement activities?
  • How often does Medical Affairs collaborate with different external groups on patient engagement activities?
  • Critical lessons learned about representing the patient voice through the Medical Affairs organization
  • Critical pitfalls or stumbling blocks observed by Medical Affairs groups in capturing and representing the patient voice

SAMPLE KEY FINDINGS

  • Internal Collaboration: Medical’s internal collaboration is most effective when engaging to understand patient outcomes and designating roles and responsibilities.

METHODOLOGY

Best Practices, LLC engaged 27 Medical leaders from 26 pharmaceutical and biotechnology companies in this research through a benchmarking survey instrument. Deep-dive interviews were conducted with selected benchmark partners to deliver further insights. Data in this study are segmented by respondents’ description of their medical team’s effectiveness with patient engagement – highly effective vs. less effective.

Industries Profiled:
Pharmaceutical; Biotech; Biopharmaceutical; Medical Device; Manufacturing; Consumer Products; Diagnostic; Health Care; Service; Consulting; Communications; Clinical Research; Laboratories


Companies Profiled:
AbbVie; Adaptimmune; Alexion Pharmaceuticals; ASC Therapeutics; Astellas; Baxter International; Bayer; bioMerieux; Boehringer Ingelheim; Boston Scientific; Chiesi; Daiichi Sankyo; Eisai; EVERSANA; Kyowa Kirin; MEDiSTRAVA; Merck; Merck Sharp & Dohme; NexGen Healthcare; Sanofi; Servier; Supernus; Takeda Pharmaceuticals; Teleflex; The Medicine Group; United Therapeutics

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.